**23andMe PGS Pharmacogenetics reports: The 23andMe test makes use of qualitative genotyping to detect 3 variants during the CYP2C19 gene, two variants from the DPYD gene and 1 variant from the SLCO1B1 gene in the genomic DNA of adults from saliva for the goal of reporting and interpreting information about the processing of specific therapeutics t